Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 40 results:
Συντάκτης Τίτλος Τύπος [ Έτος![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Φίλτρα: Συντάκτης is Panidis, Dimitrios [Clear All Filters]
Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome..
Gynecol Endocrinol. 28(1), 20-4.
(2012). Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Gynecol Endocrinol. 29(10), 926-30.
(2013). Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome..
Eur J Endocrinol. 168(2), 145-52.
(2013). The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome..
Eur J Endocrinol. 168(6), 871-7.
(2013). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome..
Hum Reprod. 28(3), 785-93.
(2013). Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)..
Gynecol Endocrinol. 29(3), 242-5.
(2013). Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome..
Hormones (Athens). 12(4), 559-66.
(2013). The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require r.
Hormones (Athens). 12(2), 192-200.
(2013). Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility..
Endocrine. 44(3), 583-90.
(2013). Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome..
Gynecol Endocrinol. 29(3), 250-3.
(2013). Prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 78(4), 586-92.
(2013). Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis..
Hormones (Athens). 13(4), 519-31.
(2014). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014). Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome..
Endocr Pract. 20(6), 540-7.
(2014). Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment..
Curr Vasc Pharmacol. 13(6), 788-800.
(2015).